Get started
Author

Ernst Havlik

Indium-111-DOTA-lanreotide: biodistribution, safety and radiation absorbed dose in tumor patients.
1998 · I Virgolini, I Szilvasi, et al. · PubMed · 86
Vasoactive intestinal peptide receptor scintigraphy.
1995 · I Virgolini, A Kurtaran, et al. · PubMed · 74
Iodine-123-vascular endothelial growth factor-165 (123I-VEGF165). Biodistribution, safety and radiation dosimetry in patients with pancreatic carcinoma.
2004 · S Li, M Peck-Radosavljevic, et al. · PubMed · 68
Response to treatment with yttrium 90-DOTA-lanreotide of a patient with metastatic gastrinoma.
1998 · M Leimer, A Kurtaran, et al. · PubMed · 54
Radiation synovectomy with (166)Ho-ferric hydroxide: a first experience.
2002 · Sedat Ofluoglu, Eva Schwameis, et al. · PubMed · 35
New radiopharmaceuticals for receptor scintigraphy and radionuclide therapy.
2000 · I Virgolini, T Traub, et al. · PubMed · 28
Effects of oral cyclotropium bromide, hyoscine N-butylbromide and placebo on gastric emptying and antral motor activity in healthy man.
1984 · G Stacher, H Bergmann, et al. · Gut · 27
PDF
Radioactive contamination of contact lenses during radioiodine therapy
2000 · G. ZETTINIG, G. KARANIKAS, et al. · Nuclear Medicine Communications · 26
Radiation synovectomy using 165Dy ferric-hydroxide and oxidative DNA damage in patients with different types of arthritis.
2000 · C Pirich, A Pilger, et al. · PubMed · 21
Effects of oral pirenzepine on gastric emptying and antral motor activity in healthy man.
1982 · G Stacher, E Havlik, et al. · PubMed · 16
Radiation alarm at an airport after radioiodine therapy
2004 · Helmut Sinzinger, Paul Aiginger, et al. · Nuclear Medicine Communications · 15
Prostaglandins as biochemical markers of radiation injury to the salivary glands after iodine-131 therapy?
1998 · Margarida Rodrigues, Ernst Havlik, et al. · European Journal of Nuclear Medicine and Molecular Imaging · 13
Increased137Caesium Whole Body Radioactivity in High-Performance Athletes
1990 · E. Havlik*, P. Haber**, et al. · International Journal of Sports Medicine · 12
Monitoring of the biodistribution and biokinetics of dysprosium-165 ferric hydroxide with a shadow-shield whole-body counter
1997 · C. Pirich, U. Pr�fert, et al. · European Journal of Nuclear Medicine and Molecular Imaging · 10
Radiation exposure from patients treated with 165Dy-ferric hydroxide
2001 · E. HAVLIK, C. PIRICH, et al. · Nuclear Medicine Communications · 9
"MAURITIUS": tumour dose in patients with advanced carcinoma.
1999 · I Virgolini, A Kurtaran, et al. · PubMed · 9
Triggering radiation alarm at security checks. Patients should be informed even after diagnostic nuclear medicine procedures.
2009 · Barbara Palumbo, Irmgard Neumann, et al. · PubMed · 8
Passive incorporation of radioisotopes and airport security
2007 · Helmut Sinzinger, Paul Aiginger, et al. · Nuclear Medicine Communications · 8
Platelet Labeling with 67Ga-MPO: A Comparison with 111In-MPO
1998 · Georgios Karanikas, Margarida Rodrigues, et al. · Nuclear Medicine and Biology · 6
[Radiosynovectomy with dysprosium-165 iron hydroxide].
1993 · C Pirich, A Wanivenhaus, et al. · PubMed · 6
Radiation doses deriving from patients undergoing 111 In-DTPA- d -Phe-1-octreotide scintigraphy
1997 · Amir Kurtaran, Josef Pfreitfellner, et al. · European Journal of Nuclear Medicine and Molecular Imaging · 5
The Use of a High-purity Germanium Detector for Routine Measurements of 125I in Radiation Workers
1994 · P. Kopp, H. Bergmann, et al. · Health Physics · 5
Technetiumspeicherung der Parotis
1976 · O. Scherak, H. Bergmann, et al. · Nuklearmedizin - NuclearMedicine · 5
Assessment of Radiocesium Incorporation in Austrians After the Chernobyl Accident
1991 · E. Havlik, H. Bergmann · Health Physics · 4
[How great is radiation exposure in the area surrounding patients after administration ov 99mTc-sestamibi?].
1997 · A Kurtaran, J Preitfellner, et al. · PubMed · 3
Works count: 59
Citation count: 571
H-index: 12
I10-index: 14
Year
Topic
Type